<qa>  What is the name of the melanoma antigen recognized by T-cellsHuman leukocyte antigens HLA-A0201 positive patients at high risk for recurrence of melanoma, or completely resected metastatic melanoma will receive immunization with peptides representing human leukocyte antigen HLA-restricted T cell epitopes of the melanoma antigen recognized by T-cells MART-1 or glycoprotein 100 gp100 melanoma antigens emulsified in Montanide ISA-51 or Montanide trademarkTM ISA 51 vegetable grade VG. Patients will be randomized to receive one of three different melanoma antigen recognized by T-cells MART-1 peptides or to receive a combination of a melanoma antigen recognized by T-cells MART-1 peptide plus a glycoprotein 100 gp100 peptide. This study is designed to evaluate the immunologic effects of the different peptide immunizations. 